TXNIP (VDUP-1, TBP-2): A major redox regulator commonly suppressed in cancer by epigenetic mechanisms

International Journal of Biochemistry and Cell Biology

Volumn 43, Issue 12, 2011, Pages 1668-1673

  Zhou, Jianbiao ^a   Yu, Qiang ^b   Chng, Wee Joo ^a,c,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c Dept Medicine Endocrinol Diabet   (Singapore)

^d NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Acute myeloid leukemia; DNA methylation; DNMT inhibitor; DZNep; Epigenetics; HDAC inhibitor; Histone modification; MicroRNA; Oxidative stress; Polycomb repressive complex 2 (PRC2); Reactive oxygen species (ROS); Solid tumor; TXNIP VDUP 1 TBP 2

Indexed keywords

3 DEAZANEPLANOCIN A; MICRORNA; POLYCOMB GROUP PROTEIN; POLYCOMB REPRESSIVE COMPLEX 2; ROMIDEPSIN; THIOREDOXIN INTERACTING PROTEIN; UNCLASSIFIED DRUG; VORINOSTAT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER THERAPY; DIGESTIVE SYSTEM CANCER; DNA METHYLATION; DNA MICROARRAY; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE SILENCING; GENE STRUCTURE; HEMATOLOGIC MALIGNANCY; HISTONE ACETYLATION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY CANCER; LARGE CELL LYMPHOMA; LIVER CELL CARCINOMA; LUNG CANCER; MELANOMA; MOLECULAR BIOLOGY; NONHUMAN; NORTHERN BLOTTING; PHEOCHROMOCYTOMA; PROMOTER REGION; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOLID TUMOR; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ANIMALIA;

EID: 80255134542     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2011.09.005     Document Type: Short Survey

References (30)

1. M.K. Ahsan, H. Masutani, Y. Yamaguchi, Y.C. Kim, K. Nosaka, and M. Matsuoka Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2 Oncogene 25 2006 2181 2191
2. L.M. Butler, X. Zhou, W.S. Xu, H.I. Scher, R.A. Rifkind, and P.A. Marks The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin Proc Natl Acad Sci U S A 99 2002 11700 11705 (Pubitemid 34994462)
3. T.F. Chai, Y.C. Leck, H. He, F.X. Yu, Y. Luo, and T. Hagen Hypoxia-inducible factor independent down-regulation of thioredoxin-interacting protein in hypoxia FEBS Lett 585 2011 492 498
4. K.S. Chen, and H.F. DeLuca Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3 Biochim Biophys Acta 1219 1994 26 32
5. W.J. Chng Micro-managing the MiRNome in SzS Blood 116 2010 1021 1022
6. K.K. Dutta, Y. Nishinaka, H. Masutani, S. Akatsuka, T.T. Aung, and T. Shirase Two distinct mechanisms for loss of thioredoxin-binding protein-2 in oxidative stress-induced renal carcinogenesis Lab Invest 85 2005 798 807 (Pubitemid 40799709)
7. M.G. Elgort, J.M. O'Shea, Y. Jiang, and D.E. Ayer Transcriptional and translational downregulation of thioredoxin interacting protein is required for metabolic reprogramming during G(1) Genes Cancer 1 2010 893 907
8. S.J. Erkeland, K.K. Palande, M. Valkhof, J. Gits, A. Danen-van Oorschot, and I.P. Touw The gene encoding thioredoxin-interacting protein (TXNIP) is a frequent virus integration site in virus-induced mouse leukemia and is overexpressed in a subset of AML patients Leukemia Res 33 2009 1367 1371
9. M. Esteller Epigenetics in cancer N Engl J Med 358 2008 1148 1159
10. D.A. Guertin, and D.M. Sabatini Defining the role of mTOR in cancer Cancer Cell 12 2007 9 22 (Pubitemid 47001784)
11. A. Holmgren, C. Johansson, C. Berndt, M.E. Lonn, C. Hudemann, and C.H. Lillig Thiol redox control via thioredoxin and glutaredoxin systems Biochem Soc Trans 33 2005 1375 1377 (Pubitemid 41779691)
12. M. Inui, G. Martello, and S. Piccolo MicroRNA control of signal transduction Nat Rev Mol Cell Biol 11 2010 252 263
13. J.H. Jeon, K.N. Lee, C.Y. Hwang, K.S. Kwon, K.H. You, and I. Choi Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1 Cancer Res 65 2005 4485 4489 (Pubitemid 40740780)
14. H.O. Jin, S.K. Seo, Y.S. Kim, S.H. Woo, K.H. Lee, and J.Y. Yi TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1 Oncogene 2011
15. A.M. Kaimul, H. Nakamura, H. Masutani, and J. Yodoi Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome Free Radical Biol Med 43 2007 861 868 (Pubitemid 47223630)
16. T. Kato, Y. Shimono, M. Hasegawa, M. Jijiwa, A. Enomoto, and N. Asai Characterization of the HDAC1 complex that regulates the sensitivity of cancer cells to oxidative stress Cancer Res 69 2009 3597 3604
17. S. Kuljaca, T. Liu, T. Dwarte, M. Kavallaris, M. Haber, and M.D. Norris The cyclin-dependent kinase inhibitor, p21(WAF1), promotes angiogenesis by repressing gene transcription of thioredoxin-binding protein 2 in cancer cells Carcinogenesis 30 2009 1865 1871
18. M. Le Bras, M.V. Clement, S. Pervaiz, and C. Brenner Reactive oxygen species and the mitochondrial signaling pathway of cell death Histol Histopathol 20 2005 205 219
19. A. Nishiyama, M. Matsui, S. Iwata, K. Hirota, H. Masutani, and H. Nakamura Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression J Biol Chem 274 1999 21645 21650
20. P. Patwari, W.A. Chutkow, K. Cummings, V.L. Verstraeten, J. Lammerding, and E.R. Schreiter Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins J Biol Chem 284 2009 24996 25003
21. P. Patwari, L.J. Higgins, W.A. Chutkow, J. Yoshioka, and R.T. Lee The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange J Biol Chem 281 2006 21884 21891 (Pubitemid 44181892)
22. S.S. Sheth, J.S. Bodnar, A. Ghazalpour, C.K. Thipphavong, S. Tsutsumi, and A.D. Tward Hepatocellular carcinoma in Txnip-deficient mice Oncogene 25 2006 3528 3536 (Pubitemid 43901674)
23. J. Takeuchi, K. Hirota, T. Itoh, R. Shinkura, K. Kitada, and J. Yodoi Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinase Antioxid Redox Signal 2 2000 83 92 (Pubitemid 30202457)
24. J. Tan, X. Yang, L. Zhuang, X. Jiang, W. Chen, and P.L. Lee Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells Genes Dev 21 2007 1050 1063 (Pubitemid 46686474)
25. K. Tomoda, Y. Kubota, and J. Kato Degradation of the cyclin-dependent- kinase inhibitor p27Kip1 is instigated by Jab1 Nature 398 1999 160 165
26. J.S. Ungerstedt, Y. Sowa, W.S. Xu, Y. Shao, M. Dokmanovic, and G. Perez Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors Proc Natl Acad Sci U S A 102 2005 673 678 (Pubitemid 40282724)
27. G.R. Yan, S.H. Xu, Z.L. Tan, L. Liu, and Q.Y. He Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics Proteomics 11 2011 912 920
28. Q. Yu Cancer gene silencing without DNA hypermethylation Epigenetics 3 2008 315 317
29. P. Zhang, C. Wang, K. Gao, D. Wang, J. Mao, and J. An The ubiquitin ligase itch regulates apoptosis by targeting thioredoxin-interacting protein for ubiquitin-dependent degradation J Biol Chem 285 2010 8869 8879
30. J. Zhou, C. Bi, L.L. Cheong, S. Mahara, S.C. Liu, and K.G. Tay The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML Blood 118 2011 2830 2839